TheraIntel Insights
Healthcare AI, Unpacked
Clinical perspectives on AI strategy, workflow automation, and the future of healthcare operations.
Utah Overrode Its Medical Board to Keep America's First AI Prescription Program Running. Pharmacies Didn't Get a Vote Either.
On April 28, 2026, Utah dismissed its own Medical Licensing Board's demand to halt the Doctronic AI prescription renewal program. Here's what telepharmacy operators and pharmacy directors need to do now.
Read article →
The AI Governance Liability Bomb: 75% of Health Systems Are Already Exposed
Three in four health systems have deployed AI. Only 18% have a formal governance policy. This isn't a technology gap — it's an active compliance liability that will be triggered by your next payer audit, regulatory inspection, or patient safety event.
CMS's April 2026 Drug ePA Rule Creates Two-Track Standards — and Most Pharmacy Systems Are Only Built for One
CMS's April 10, 2026 proposed rule separates drug prior authorization into FHIR and NCPDP tracks, with an October 2027 compliance deadline most pharmacy teams aren't planning for.
The FDA Just Made AI Overreliance a Regulatory Violation
The first FDA cGMP warning letter to cite AI misuse as a standalone deficiency landed April 2, 2026. For pharmacy directors running AI in regulated workflows, this is the line of demarcation.
Autonomous AI Prescribing Has Arrived. The FDA Still Hasn't Defined Its Authority.
Utah's Doctronic pilot exposes a jurisdiction gap that no health system is prepared for — and pharmacy is squarely in the middle. Here's what that means for your operations right now.
CMS Just Flipped the Prior Authorization Equation for Drugs
A four-day-old proposed rule forces AI accountability into pharmacy — and the comment window closes June 15, 2026. Here's what every pharmacy director needs to do before then.
The AI Billing Gap: What the 2026 CPT Codes Don't Tell You
CPT 2026 gave healthcare AI its first billing vocabulary. CMS declined to fund most of it. Here is the financial and compliance trap healthcare leaders are walking into.
The Pilot Trap: Why 76% of Healthcare AI Programs Can't Scale — And What to Do About It
Health systems aren't failing at AI because the technology is broken. They're failing because the adoption model they inherited from traditional software procurement doesn't apply to clinical AI.
The April 1 Deadline Your Health System Probably Missed
CMS and FDA opened the first outcome-aligned payment pathway for AI-enabled chronic care. Applications close April 1, 2026. Most clinical leaders haven't filed — and most don't know why that matters yet.
Agentic AI Is Reshaping Telepharmacy — And Most Health Systems Are Missing the Play
Walgreens fills 60% of prescriptions with robotics. CVS deploys AI across 9,000 locations. Yet 81% of hospital pharmacy operations haven't adopted AI at any level. The gap isn't a technology problem — it's a strategic framing problem.
FDA's 2026 CDS Guidance Makes Transparency Non-Negotiable — What Telepharmacy Operators Must Do Now
The FDA's January 2026 Clinical Decision Support guidance dismantles the black-box era in clinical AI. For telepharmacy operators, the compliance window is already open.
Why Most EHR-Integrated AI Tools Fail at the Point of Care — And What Actually Works
Clinicians in AI-enabled health systems are receiving up to 200 alerts per day. They override 96% of them. The problem isn't the AI. It's the integration strategy.